Shortage Of Weight-Loss Drugs Like Wegovy And Ozempic Persist—And Could For ‘Some Years’

Diabetes drugs Wegovy and Ozempic, which have gained popularity as weight-loss drugs, face major supply issues, drugmaker Novo Nordisk admitted, as the company struggles with surging demand.

Subscribe

Related articles

Avatar